HC
TEVA icon

Hurley Capital’s Teva Pharmaceuticals TEVA Stock Holding History

Hurley Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.39K Hold
100
– – ﹤0.01% 509
2026
Q1 		$3.01K Hold
100
– – ﹤0.01% 527
2025
Q4 		$3.12K Hold
100
– – ﹤0.01% 485
2025
Q3 		$2.02K Hold
100
– – ﹤0.01% 516
2025
Q2 		$1.68K Hold
100
– – ﹤0.01% 403
2025
Q1 		$1.54K Hold
100
– – ﹤0.01% 430
2024
Q4 		$2.12K Buy
+100
New +$1.82K ﹤0.01% 354

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Hurley Capital's TEVA Position: Q2 2026 in Review

Hurley Capital held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 100 shares worth $3.39K. The position accounts for ﹤0.01% of the portfolio, ranked #509.

Hurley Capital first reported a position in TEVA in Q4 2024 and has held it in 7 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Hurley Capital held 100 shares of Teva Pharmaceuticals worth $3.39K as of Q2 2026.
  • Hurley Capital left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Hurley Capital's portfolio in Q2 2026, its #509 holding.
  • Hurley Capital first reported a position in Teva Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Hurley Capital's 13F filing for Q2 2026, filed 10 Aug 2026.